Literature DB >> 13950791

Energy matabolism in the erythrocytes of permature infants compared to full term newborn infants and adults.

R T GROSS, E A SCHROEDER, S A BROUNSTEIN.   

Abstract

Entities:  

Keywords:  ENERGY METABOLISM; ERYTHROCYTES; INFANT, PREMATURE

Mesh：

Year:  1963        PMID： 13950791

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  HUMAN FETL ERYTHROCYTE AND PLASMA LIPIDS.

Authors:  J CROWLEY; P WAYS; J W JONES
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

2.  Pyridine nucleotides in erythrocyte metabolism.

Authors:  R T Gross; E A Schroeder; B W Gabrio
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

3.  [2,3-diphosphoglycerate metabolism in the erythrocytes of the newborn and of adults].

Authors:  W Schröter; P Winter
Journal:  Klin Wochenschr       Date:  1967-03-01

4.  [Comparative biochemical studies of erythrocytes from the blood of the newborn and of adults].

Authors:  I Witt; H Müller; W Künzer
Journal:  Klin Wochenschr       Date:  1967-03-01

Review 5.  Bilirubin and red cell metabolism in relation to neonatal jaundice.

Authors:  T Valaes
Journal:  Postgrad Med J       Date:  1969-02       Impact factor: 2.401

6.  [Hexokinase isoenzymes in normal erythrocytes of adults and newborns and in various hyperregenerative anemias].

Authors:  W Tillmann; W Schröter
Journal:  Klin Wochenschr       Date:  1969-07-15

7.  A study of the relationship between the content of adenosine triphosphate in human red cells and the course of falciparum malaria: a new system that may confer protection against malaria.

Authors:  G J Brewer; R D Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

8.  Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes.

Authors:  E R Jaffé; E L Gottfried
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.